Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1977-10-05
1978-10-17
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Lymphokine
424 78, A61K 3174, A61K 3179
Patent
active
041209494
ABSTRACT:
An ophthalmic solution is disclosed comprising an aqueous solution of polyvinyl alcohol, hydroxyethyl cellulose, polyvinylpyrrolidone, and, optionally, hydroxypropyl methylcellulose. The ophthalmic solution is used in treating dry eye syndrome due to insufficient tear production in humans and mammals, and as an ocular lubricant for inflamed eyes.
REFERENCES:
patent: 2861920 (1958-11-01), Dale et al.
patent: 3311577 (1967-03-01), Rankin
patent: 3843782 (1974-10-01), Krezanoski et al.
patent: 3856919 (1974-12-01), Rankin
patent: 3868445 (1975-02-01), Ryde et al.
patent: 3920810 (1975-11-01), Rankin
patent: 3927205 (1975-12-01), Ohno et al.
The Merck Index, 8th Ed., p. 393 (1968).
Bapatla Krishna M.
Brychta Katharyn M.
Boland Thomas R.
Cooper Laboratories, Inc.
Kolano John J.
Meyers Albert T.
Robinson D. W.
LandOfFree
Ophthalmic solution does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ophthalmic solution, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic solution will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-375824